Research-Grade Peptides | 99%+ Purity Verified | US Delivery 2–5 Days
Save 5% with Crypto
SaiyanMed

Your Cart

No products in the cart.

GHK-Cu Salt Forms Explained: GHK vs GHK-Cu, Acetate vs HCl, 1:1 vs 2:1, Prezatide Copper and the Copper-Ratio Check

Illustration of GHK-Cu salt forms: peptide, copper complex and counter-ions

Last updated: 2026-10-29 · Written by: SaiyanMed Research Team · Reading time: about 20 minutes

Quick answer: ‘GHK-Cu’ is a label, not a single substance. It can mean copper-free GHK, the 1:1 copper(II) complex (registered by FDA’s substance system as prezatide copper, CAS 89030-95-5, 401.91 g/mol), that complex isolated with an acetate or chloride counter-ion, or a 2:1 peptide-to-copper material such as the INN substance prezatide copper acetate (CAS 130120-57-9, 862.39 g/mol).[9][10] Acetate and chloride change only the mass that travels with each copper–peptide unit: ideal copper content is 15.81% (no counter-ion), 14.50% (chloride), 13.76% (acetate) and 7.37% (prezatide copper acetate), by our calculation. Neither colour nor HPLC purity distinguishes these forms. A measured copper-to-peptide molar ratio does.

Key takeaways

  • Two registry anchors, two ratios. GSRS lists prezatide copper (Copper Tripeptide-1) as the 1:1 complex, C14H22N6O4·Cu, and prezatide copper acetate as a bis-peptide copper diacetate. The similar names hide a two-fold difference in copper per peptide.[9][10]
  • The counter-ion sits on lysine. Near neutral pH the 1:1 complex carries a net +1 charge, from the protonated lysine side chain, so a solid needs one anion: one acetate or one chloride per copper.
  • HCl and acetate grades usually share a CAS. Raw-material suppliers and China’s 2026 cosmetic-ingredient standard put both under 89030-95-5, with different content limits for each form. Cayman uses 300801-03-0 for its mono-acetate.[15][17]
  • HPLC splits the complex. In the official TFA-acidified HPLC method, copper and the peptide elute as two separate peaks, at 3.3 and 5.7 min. A single ‘purity’ figure therefore cannot tell you the ratio.[17]
  • Ratio check (calculated): (Cu% ÷ 63.546) ÷ (GHK% ÷ 340.38). A value near 1.0 indicates 1:1 and near 0.5 indicates 2:1.

How GHK holds copper

GHK is glycyl-L-histidyl-L-lysine, C14H24N6O4, 340.38 g/mol (CAS 49557-75-7).[11] It was identified as a copper-binding plasma factor around 1980, and its affinity for Cu(II) is what makes ‘GHK-Cu’ a distinct material.[5] Copper binding uses three nitrogen atoms at the N-terminal end of the peptide:

  • the free α-amino nitrogen of glycine;
  • the deprotonated amide nitrogen of the Gly–His peptide bond;
  • an imidazole nitrogen of histidine.

Solution EPR work and later crystallography agree on this 3-nitrogen core. A fourth equatorial position is occupied by a labile oxygen donor: water in solution or, in the crystal, a carboxylate oxygen from a neighbouring complex.[2][3] Hureau and co-workers describe the crystal as dimeric and the solution complex as monomeric.[2] The bridging carboxylate is the C-terminal carboxylate. It belongs to the lysine residue, but it is not the lysine side chain. The lysine ε-amino group takes no part in copper binding.

Charge bookkeeping explains the salt forms. Cu2+ contributes +2, the deprotonated amide −1, the C-terminal carboxylate −1 and the protonated lysine ε-amine (pKa 10.44) +1.[1] Near pH 7 the net charge is therefore +1, which matches PubChem’s cation record C14H23CuN6O4+ (402.92 g/mol).[12] Registries also write a ‘neutral’ formula, C14H22CuN6O4 (401.91 g/mol), with one hydrogen fewer.[9] It is best read as a bookkeeping formula. A real solid near neutral pH carries one anion per copper, and the formulas show this exactly. Cation + acetate (C16H26CuN6O6) has the same atoms as Cayman’s ‘401.91 complex · acetic acid’. Cation + chloride has the same atoms as ‘401.91 complex · HCl’.[15]

Two copper complexes side by side: on the left one short peptide wraps a single orange copper sphere, on the right two peptides share one copper sphere.

What exists in solution: pH, speciation and exchange

The most complete potentiometric study is still Lau and Sarkar (1981), measured at 25 °C in 0.15 M NaCl.[1] Their key numbers:

Quantity Value What it means for salt forms
pKa carboxyl 2.91 Below about pH 3 the carboxylate is protonated.
pKa imidazole 6.53 Histidine must be deprotonated to bind copper.
pKa α-amino 7.93 The glycine nitrogen is a copper ligand.
pKa ε-amino (Lys) 10.44 Stays protonated near pH 7, so a counter-ion is needed.
log K, main 1:1 species (MA) 16.44 Very tight binding. By comparison, Gly-His gives 8.68 and Gly-His-Gly 8.52.
Onset of copper binding ≈ pH 3 Strong acid strips copper from the peptide.
Visible absorption maximum ≈ 610 nm The source of the blue colour.
Values from Lau & Sarkar 1981.[1] Note that the log K values for Gly-His and Gly-His-Gly are formation constants defined for those ligands’ own protonation schemes. Compare constants of this kind only within a single study.

Lau and Sarkar also identified a family of species beyond the 1:1 complex, including bis-ligand forms (MA2, MHA2, MH2A2, and deprotonated variants) that appear when GHK is in excess.[1] Hureau and co-workers found that copper exchange between GHK molecules is fast and assigned it to a transient [Cu(GHK)2] species.[2] Using isothermal titration calorimetry, Trapaidze et al. confirmed predominantly 1:1 binding, with a conditional dissociation constant of 7.0 × 10−14 M at pH 7.4.[4] Freedman et al. used optical and EPR spectroscopy and found a mononuclear 1:1 complex at neutral pH, with apparent transitions at pK 3.6 (copper binding), 9.2 and 11.4. They also found that the polymeric, oxygen-bridged structure of the solid does not persist in solution.[3] Three practical consequences follow:

  • A ‘2:1’ powder is not a fixed 2:1 molecule once dissolved. Near neutral pH the first GHK binds through three nitrogens. The second is held much more weakly and exchanges, so the solution is an equilibrium mixture of 1:1, bis and free-peptide species (our inference from the speciation data).
  • Copper in the complex can be displaced or bound by other ligands. At equimolar albumin and GHK, Lau and Sarkar found that about 42% of the copper stayed with GHK.[1] Later work characterised ternary Cu(GHK)–albumin complexes formed through histidine imidazoles of albumin, and ternary complexes with imidazole and urocanic acid.[6][8] Glutathione reduces Cu(II)GHK to Cu(I) through a transient thiolate intermediate.[7]
  • Acid takes the copper off. Because binding begins only around pH 3,[1] the complex is not expected to survive 0.1% TFA (pH about 2). The official HPLC method relies on exactly this (see below).

Names, formulas and CAS numbers

Material GHK : Cu : anion Formula MW (g/mol) CAS Primary source
GHK (copper-free) 1 : 0 : 0 C14H24N6O4 340.38 49557-75-7 PubChem[11]
GHK acetate (copper-free) 1 : 0 : 1 AcOH C14H24N6O4·C2H4O2 400.43 72957-37-0 PubChem; Sigma G1887[16]
Prezatide copper / Copper Tripeptide-1 (1:1, written neutral) 1 : 1 : 0 C14H22N6O4·Cu 401.91 89030-95-5 FDA GSRS, UNII 6BJQ43T1I9[9]
1:1 cation 1 : 1 : 0 C14H23CuN6O4+ 402.92 (89030-95-5 resolves here) PubChem CID 71587328[12]
GHK-Cu acetate (1:1 mono-acetate) 1 : 1 : 1 C14H22CuN6O4·C2H4O2 462.0 (Cayman); 461.97 calc. 300801-03-0 Cayman 28259[15]
GHK-Cu chloride / ‘HCl’ (1:1) 1 : 1 : 1 C14H22CuN6O4·HCl 438.37 (calculated) No form-specific registry entry found; suppliers use 89030-95-5 YY/T 10005 covers ‘salts’[17]
Bisprezatide copper (2:1) 2 : 1 : 0 C28H46CuN12O8 742.3 130120-56-8 PubChem CID 9831891[13]
Prezatide copper acetate (INN; 2:1 diacetate) 2 : 1 : 2 C32H54CuN12O12 862.39 130120-57-9 FDA GSRS, UNII A3LEI4P1NB[10][14]
Formulas and MWs are taken from the cited records. Where a value is marked ‘calculated’, we computed it from standard atomic weights (C 12.011, H 1.008, N 14.007, O 15.999, Cl 35.45, Cu 63.546). Caution: PubChem links CAS 300801-03-0 to several records, including deposits with differing protonation states. Treat 300801-03-0 as the identifier Cayman uses for its mono-acetate, not as a universally agreed registry identity.

Two naming traps stand out. First, prezatide copper (1:1) and prezatide copper acetate (bis-peptide diacetate) are different substances whose GSRS records differ by more than a factor of two in mass.[9][10] GSRS describes the latter as a cuprate with one GHK bound in the tridentate N,N,N mode and a second GHK bound only through a histidine imidazole nitrogen, together with a proton and two acetates.[10] Its synonyms include PC-1020 and Iamin. Second, ‘GHK acetate’ from a general catalogue contains no copper at all.[16]

Acetate vs chloride

In both forms the copper–peptide cation is identical. What differs is the anion that balances the lysine charge, and with it the general salt behaviour described for peptides in general.[19]

Property Acetate Chloride (‘HCl’) Evidence level
Counter-ion mass per copper 59.04 (CH3COO−) 35.45 (Cl−) Arithmetic
Ideal MW (1:1, anhydrous) 461.97 438.37 Calculated
Ideal copper content 13.76% 14.50% Calculated
Ideal GHK content 73.68% 77.65% Calculated
Registry/datasheet identity Cayman mono-acetate, CAS 300801-03-0[15] No form-specific entry found Primary records
Volatility of counter-ion Acetic acid is volatile and can be partly lost on drying, so the acetate level varies from lot to lot Chloride is non-volatile General chemistry; YY/T sets an acetic-acid limit of ≤15.0%[17]
Solution pH, stability, solubility No head-to-head published data found No head-to-head published data found Unknown
We found no peer-reviewed study comparing the acetate and chloride forms of GHK-Cu for stability, solubility or any biological property. Supplier statements that one form is ‘more hygroscopic’ or ‘cleaner dissolving’ are unsupported by data that we could locate.
Three panels: a short grey peptide with no metal, the same peptide holding an orange copper ion beside small acetate counter-ions, and the same complex beside single-sphere chloride counter-ions.

1:1 vs 2:1 and prezatide copper acetate

A 2:1 material carries one extra GHK per copper. At an ideal stoichiometry this roughly halves the copper per milligram, from 15.81% to 8.56% without counter-ions (our calculation). As the speciation data show, the second peptide is held loosely and exchanges in solution.[1][2] A 2:1 label is therefore a statement about how much of each component is present, not about a single molecule that stays intact once dissolved. The INN/USAN substance prezatide copper acetate (development code PC-1020) is of this bis-peptide type.[10] Many current raw-material suppliers, and China’s 2026 standard, define Copper Tripeptide-1 as the 1:1 complex instead.[9][17]

Copper content, calculated

Every percentage in this table is a SaiyanMed calculation for ideal, anhydrous stoichiometry. Formula: Cu% = 63.546 × nCu ÷ MW × 100, and GHK% = 340.38 × nGHK ÷ MW × 100.

Form MW used Cu % GHK % Cu–GHK (1:1, as C14H22CuN6O4) % Expected Cu : GHK
1:1, neutral formula 401.91 15.81 84.69 100.0 1.00
1:1 chloride 438.37 14.50 77.65 91.68 1.00
1:1 acetate 461.97 13.76 73.68 87.00 1.00
2:1, no counter-ion 742.30 8.56 91.71 — 0.50
Prezatide copper acetate (2:1:2) 862.40 7.37 78.94 — 0.50
GHK acetate (no Cu) 400.44 0 85.00 — 0
Worked line, acetate: 63.546 ÷ 461.97 = 0.1376, so 13.76%. Using Cayman’s rounded FW of 462.0 gives 13.75%. Real lots also contain water and variable residual counter-ion, and sometimes excess acetate, so ‘as-is’ values come out lower. The 2026 Chinese standard therefore reports content on an anhydrous basis.

The ratio check, worked

The ratio check needs two independent measured contents on the same basis: copper (for example by ICP-OES or ICP-MS) and peptide (for example by amino-acid analysis, quantitative NMR or external-standard HPLC). Water and counter-ion content cancel, because both numbers are fractions of the same powder.

  • Example A (calculated): Cu 13.5%, GHK 72.0%. Then (13.5 ÷ 63.546) ÷ (72.0 ÷ 340.38) = 0.2124 ÷ 0.2115 = 1.00, which is consistent with 1:1.
  • Example B (calculated): Cu 7.0%, GHK 72.0%. Then 0.1102 ÷ 0.2115 = 0.52, which is consistent with a 2:1 material or a 1:1 material short of copper. The ratio cannot distinguish these two cases. Ask how the material was made.
  • Example C (calculated): taking the acetate-form minimums of YY/T 10005 (Cu ≥13.0%, tripeptide-1 ≥65.0%) gives 0.2046 ÷ 0.1910 = 1.07. A lot sitting at both minimums would therefore carry slightly more copper than peptide. Values much above 1.0 suggest unbound or excess copper.[17]

Because the ratio is a quotient, its uncertainty combines both measurements. Suppose each measurement carries a ±3% relative error. The ratio then carries about ±4% when the errors are independent, and up to ±6% in the worst case. On that basis, a result between about 0.94 and 1.06 is consistent with 1:1 (our approximation). Treat small deviations with caution.

How each property is measured

Question Method What it shows Limitation
Total copper ICP-OES / ICP-MS after digestion Mass fraction of Cu Cannot distinguish bound from free Cu
Peptide content Amino-acid analysis, qNMR, external-standard HPLC Mass fraction of GHK HPLC area % is not content[20]
Bound vs free copper Ultrafiltration or chelator-competition with ICP; UV-vis Free Cu(II) Method-dependent; disturbs the equilibrium
Coordination UV-vis d–d band ≈ 605–610 nm; aqua Cu(II) ≈ 816 nm 1:1 complex vs free Cu; a ternary ligand on imidazole shifts the band to ≈ 565 nm Bis and ternary species overlap[1][6][7]
Coordination geometry EPR 3N(+1O) Cu(II) site Specialist method[2][3]
Identity of the ligand MS (GHK [M+H]+ m/z ≈ 341.19, calc.) The peptide sequence and mass Cu adducts in the source are not proof of the solid ratio
Counter-ion Ion chromatography (Cl−, acetate, TFA); pharmacopoeial acetate test Which salt it is, and how much Must be requested explicitly[17]
Water Karl Fischer Moisture basis —
The MS value is our monoisotopic calculation for C14H25N6O4+. Read more in what mass spectrometry can and cannot confirm.

What the 2026 standard specifies

China’s NMPA issued YY/T 10005—2026, Cosmetic ingredients — Copper tripeptide-1, on 3 April 2026. It is a recommended (non-mandatory) industry standard, effective 1 May 2027.[17][18] We cite it here as the first published specification we found that separates salt forms. It defines Copper Tripeptide-1 as C14H22CuN6O4, CAS 89030-95-5, 401.91, and applies to ‘copper tripeptide-1 and its salts’.[17]

Item (anhydrous basis) Salt-free Hydrochloride Acetate Ideal value, calc. (salt-free / HCl / acetate)
Copper Tripeptide-1 content ≥ 91.0% ≥ 83.0% ≥ 78.0% 100 / 91.7 / 87.0%
Tripeptide-1 content ≥ 78.0% ≥ 70.0% ≥ 65.0% 84.7 / 77.6 / 73.7%
Copper content ≥ 13.0% (all forms) 15.8 / 14.5 / 13.8%
HPLC purity ≥ 98.0%
Water ≤ 8.0%
Acetic acid ≤ 15.0%
Limits from YY/T 10005—2026.[17] The comparison column is our calculation. One consequence: the copper floor of 13.0% cannot be met by any 2:1 material, whose ideal values are 8.56% or 7.37%. The standard therefore effectively specifies the 1:1 complex.

The test method (Appendix A) is reversed-phase HPLC on a C18 column, with 0.1% TFA in water and acetonitrile and detection at 220 nm. It is calibrated against GHK and copper(II) chloride dihydrate reference standards. In the reference chromatogram copper elutes at 3.298 min and tripeptide-1 at 5.729 min: two separate peaks. Copper Tripeptide-1 ‘content’ is defined as the sum of the copper and tripeptide-1 contents, and purity is calculated from the combined copper and peptide peak areas.[17] This confirms that acidic HPLC does not preserve the complex. It also shows that a vendor’s ‘99% HPLC’ can mean quite different things, depending on whether the copper peak was integrated.

COA checklist

  • Name, INCI (Copper Tripeptide-1), stated ratio (1:1 or 2:1) and stated counter-ion.
  • A CAS that matches the material: 49557-75-7 means no copper. 130120-57-9 means a bis-peptide acetate.
  • Copper content with method (ICP) and basis (as-is or anhydrous).
  • Peptide content with method. This is not the same as HPLC purity.
  • The ratio calculated from the two values above; it should be close to 1.0 or 0.5 as claimed.
  • HPLC method: was the copper peak included in the purity figure?
  • Water (Karl Fischer) and counter-ion assay (acetate, chloride, residual TFA).
  • Identity by MS for the peptide; UV-vis λmax recorded if available.
  • A batch number that matches the vial, plus the release date and signatory. See how to read a peptide COA.

Myths versus evidence

Claim What the evidence shows
‘Acetate is more stable or bioavailable than HCl’ No head-to-head data found for GHK-Cu. Only the mass and identity of the counter-ion are established.
‘Blue means pure 1:1’ Both 1:1 and bis/ternary species are coloured. The band shifts but does not disappear.[1][6]
‘99% HPLC = 99% GHK-Cu’ Under the official method the complex dissociates on the column, and purity is a combined peak-area figure.[17]
‘Prezatide copper is the 1:1 GHK-Cu’ Only partly. GSRS ‘prezatide copper’ is 1:1, but the INN ‘prezatide copper acetate’ is a 2:1 diacetate.[9][10]
‘GHK acetate is a cheaper GHK-Cu’ It contains no copper.[16]
‘2:1 is a stronger GHK-Cu’ It carries about half the copper per mg, and the second peptide exchanges in solution.[1][2]
‘The copper is locked in permanently’ Exchange is fast. Albumin and other ligands compete or form ternary complexes, and glutathione reduces the copper.[1][2][7][8]
‘Each salt has its own CAS’ Suppliers and YY/T use 89030-95-5 for both salts. Only Cayman’s acetate uses a separate number.[15][17]

Glossary

  • Counter-ion: the ion that balances the charge on the complex in a solid (here acetate or chloride).
  • Copper Tripeptide-1: the INCI (cosmetic ingredient) name for the GHK–copper complex.
  • Prezatide copper / prezatide copper acetate: GSRS and INN names for the 1:1 complex and the 2:1 diacetate, respectively.
  • log K / stability constant: a logarithmic measure of how strongly a ligand binds a metal under defined conditions.
  • Speciation: the distribution of a metal across different complexes at a given pH and set of concentrations.
  • Ternary complex: a complex in which copper is bound by two different ligands, such as GHK plus imidazole or albumin.
  • d–d band: the weak visible absorption of Cu(II) that gives the colour.
  • Anhydrous basis: a result recalculated after subtracting the measured water content.
  • ICP-OES/MS: plasma-based elemental analysis used to measure total copper.

Frequently asked questions

Is GHK the same as GHK-Cu?

No. GHK is the copper-free tripeptide Gly-His-Lys (C14H24N6O4, 340.38 g/mol, CAS 49557-75-7). GHK-Cu is its copper(II) complex. FDA’s GSRS lists the 1:1 complex as prezatide copper (Copper Tripeptide-1), C14H22N6O4·Cu, 401.91 g/mol, CAS 89030-95-5.

What is the difference between GHK-Cu acetate and GHK-Cu HCl?

Both contain the same 1:1 copper–peptide cation. One acetate or one chloride balances the positive charge on lysine. Ideal copper content is 13.76% for the acetate and 14.50% for the chloride (calculated). We found no published head-to-head stability or solubility data for the two forms.

Which CAS number is correct for GHK-Cu?

89030-95-5 is the 1:1 complex (GSRS). Suppliers use it for both the acetate and the HCl grade. 300801-03-0 is used by Cayman for its mono-acetate. 130120-57-9 is prezatide copper acetate, a 2:1 diacetate. 49557-75-7 is GHK with no copper.

Is prezatide copper the same as GHK-Cu?

GSRS ‘prezatide copper’ is the 1:1 GHK–copper complex. ‘Prezatide copper acetate’, the INN/USAN substance, is a different, bis-peptide composition (two GHK per copper, plus two acetates, MW 862.39).

What does GHK-Cu 2:1 mean?

Two GHK molecules per copper ion. Ideal copper content falls to 8.56% without counter-ions (calculated). In solution the second peptide is weakly held and exchanges.

Why is GHK-Cu blue, and why might it look purple?

The Cu(II) d–d band near 605–610 nm makes the 1:1 complex blue. When an extra ligand such as imidazole binds, the band shifts toward about 565 nm, so the colour can move toward violet. Colour cannot confirm the ratio.

Does HPLC purity measure GHK-Cu?

Not as an intact complex. In the TFA-acidified method of YY/T 10005—2026, copper and the peptide elute as separate peaks, and copper content has to be quantified separately.

How do you check the copper ratio from a COA?

Divide copper % by 63.546 and peptide % by 340.38, then take the quotient. A value near 1.0 indicates 1:1 and one near 0.5 indicates 2:1. Both values must be measured contents on the same basis.

Related reading

About the author: SaiyanMed Research Team. Sources for this article were primary coordination-chemistry papers, FDA GSRS and PubChem records, manufacturer datasheets and the NMPA standard text. Values we derived ourselves are marked calculated.

Last updated: 2026-10-29

References

  1. Lau S.-J., Sarkar B. The interaction of copper(II) and glycyl-L-histidyl-L-lysine, a growth-modulating tripeptide from plasma. Biochem J 1981;199:649–656. doi:10.1042/bj1990649
  2. Hureau C., Eury H., Guillot R., et al. X-ray and solution structures of CuIIGHK and CuIIDAHK complexes: influence on their redox properties. Chem Eur J 2011;17:10151–10160. doi:10.1002/chem.201100751 (open-access author version)
  3. Freedman J.H., Pickart L., Weinstein B., Mims W.B., Peisach J. Structure of the glycyl-L-histidyl-L-lysine–copper(II) complex in solution. Biochemistry 1982;21:4540–4544. doi:10.1021/bi00262a004
  4. Trapaidze A., Hureau C., Bal W., Winterhalter M., Faller P. Thermodynamic study of Cu2+ binding to the DAHK and GHK peptides by isothermal titration calorimetry (ITC) with the weaker competitor glycine. J Biol Inorg Chem 2012;17:37–47.
  5. Pickart L., Freedman J.H., Loker W.J., et al. Growth-modulating plasma tripeptide may function by facilitating copper uptake into cells. Nature 1980;288:715–717.
  6. Bossak-Ahmad K., Wiśniewska M.D., Bal W., Drew S.C., Frączyk T. Ternary Cu(II) complex with GHK peptide and cis-urocanic acid… Int J Mol Sci 2020;21:6190.
  7. Ufnalska I., Drew S.C., Zhukov I., et al. Intermediate Cu(II)-thiolate species in the reduction of Cu(II)GHK by glutathione. Inorg Chem 2021;60:18048–18057.
  8. Bossak-Ahmad K., Bal W., Frączyk T., Drew S.C. Ternary Cu2+ complexes of human serum albumin and glycyl-L-histidyl-L-lysine. Inorg Chem 2021;60:16927–16931.
  9. U.S. FDA Global Substance Registration System (GSRS): PREZATIDE COPPER, UNII 6BJQ43T1I9, C14H22N6O4·Cu, MW 401.91, CAS 89030-95-5; synonyms include COPPER TRIPEPTIDE-1 and GHK COPPER.
  10. U.S. FDA GSRS: PREZATIDE COPPER ACETATE [INN, USAN], UNII A3LEI4P1NB, MW 862.39, CAS 130120-57-9; synonyms BIS(TRIPEPTIDE-1) COPPER ACETATE, GHK BIS COMPLEX WITH COPPER DIACETATE, PC-1020, Iamin.
  11. PubChem: glycyl-L-histidyl-L-lysine (GHK), CID 73587, C14H24N6O4, 340.38 g/mol.
  12. PubChem: Prezatide copper, CID 71587328 (cation C14H23CuN6O4+, 402.92 g/mol).
  13. PubChem: Bisprezatide copper, CID 9831891, C28H46CuN12O8, 742.3 g/mol (CAS 130120-56-8 resolves here).
  14. PubChem: Prezatide copper acetate, CID 9876021, C32H54CuN12O12, 862.4 g/mol.
  15. Cayman Chemical. GHK-Cu (acetate), item 28259: [glycyl-κN-L-histidyl-κN,κN3-L-lysinato(2-)]-copper, monoacetate; C14H22CuN6O4·C2H4O2, FW 462.0, CAS 300801-03-0.
  16. PubChem CID 22214678 (Gly-His-Lys acetate; CAS 72957-37-0). Sigma-Aldrich catalogue G1887 lists it as C14H24N6O4·C2H4O2, MW 400.43, CAS 72957-37-0, peptide content ~70%.
  17. National Medical Products Administration (China). YY/T 10005—2026, Cosmetic ingredients — Copper tripeptide-1. Issued 2026-04-03, effective 2027-05-01 (PDF, Chinese).
  18. National Public Service Platform for Standards Information (China): YY/T 10005—2026 record and status.
  19. Sikora K. et al. The role of counter-ions in peptides: an overview. Pharmaceuticals 2020;13:442.
  20. Wang X. et al. Purity determination of synthetic glucagon using a mass balance approach. Sci Rep 2020;10:4423.
  21. Pickart L., Margolina A. Regenerative and protective actions of the GHK-Cu peptide in the light of the new gene data. Int J Mol Sci 2018;19:1987. (Background review.)

Additional sources mentioned in the text without links: Perkins C.M. et al. Inorg Chim Acta 1984;82:93–99, a 1.1 Å crystal structure of a Cu–GHK complex, doi:10.1016/S0020-1693(00)82544-X.

Research Use Only Disclaimer

This article is a chemistry and analytical-science explainer. It is not medical advice and contains no administration, dosing or efficacy information for people or animals. Studies are described for chemical context only.